Menstrual bleeding, hormones, and the menopausal transition.
The perimenopause represents a time of great variability in reproductive hormone dynamics and menstrual cycle characteristics, but age-related changes begin prior to this. These changes include a gradual increase in follicle stimulating hormone (FSH) levels, a gradual shortening of mean cycle length, and a decline in the number of ovarian follicles. The onset of perimenopause is thought to occur with the first break in menstrual cycle regularity. With the onset of cycle irregularities, hormone concentrations exhibit large increases in variability and unpredictability, rather than following a gradual trend with the approach of menopause, the final menstrual period. Abrupt spikes in gonadotropins and considerable fluctuations in estradiol and inhibin levels have been observed. Variability is the norm in the perimenopause, with hormonal fluctuations contributing to the visible signs of menstrual cycle and bleeding irregularities. To date there is no single endocrine indicator to serve as an adequate marker of menopausal status. This paper provides a review of research to date on patterns of reproductive hormones and menstrual bleeding during the menopausal transition. An understanding of such patterns can contribute to a better ability to distinguish "normal" transitional events from more serious pathology.
Johannes
C B
CB
New England Research Institutes, Watertown, MA 02472, USA.
Crawford
S L
SL
D000328:Adult; D000375:Aging / Q000502:physiology; D015415:Biomarkers; D005260:Female; D005640:Follicle Stimulating Hormone / Q000032:analysis / Q000494:pharmacology; D006062:Gonadotropins / Q000032:analysis* / Q000494:pharmacology; D006801:Humans; D008598:Menstruation / Q000502:physiology*; D008875:Middle Aged; D006080:Ovarian Follicle / Q000502:physiology; D017697:Premenopause / Q000502:physiology*
D015415:Biomarkers; D006062:Gonadotropins; D005640:Follicle Stimulating Hormone